Synthesis, Biological Evaluation, and In Silico Characterization of Novel Imidazothiadiazole–Chalcone Hybrids as Multi-Target Enzyme Inhibitors

Synthesis, Biological Evaluation, and In Silico Characterization of Novel Imidazothiadiazole–Chalcone Hybrids as Multi-Target Enzyme Inhibitors

<b>Background/Objectives:</b> The need for dual-targeted enzyme inhibitors is critical in addressing complex diseases like Alzheimer’s and glaucoma. Imidazothiadiazole and chalcone moieties are known for diverse bioactivities. This study aimed to develop novel imidazothiadiazole–chalcone...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hakan Alici, Senol Topuz, Kadir Demir, Parham Taslimi, Hakan Tahtaci
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Pharmaceuticals
Subjects:	imidazothiadiazole chalcone hybrids carbonic anhydrase inhibitors acetylcholinesterase inhibitors butyrylcholinesterase inhibitors molecular docking
Online Access:	https://www.mdpi.com/1424-8247/18/7/962
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fluorometric and Colorimetric Biosensors for the Assay of Cholinesterase Inhibitors
by: Miroslav Pohanka
Published: (2025-04-01)

Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase
by: Ante Miličević, et al.
Published: (2022-04-01)

Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility
by: Vincenzo Condello, et al.
Published: (2025-06-01)

In silico screening of naturally derived dietary compounds as potential butyrylcholinesterase inhibitors for Alzheimer’s disease treatment
by: Md. Tarikul Islam, et al.
Published: (2025-05-01)

Inhibitory Effects of Chalcone on the Replication of Poliovirus in Vitro
by: Baghdad Science Journal
Published: (2013-06-01)

The Effect of 3′,4′-Methylenedioxychalcone Derivatives on Mycelial Growth and Conidial Germination of <i>Monilinia fructicola</i>: An In Silico and In Vitro Study
by: Catalina Ferreira, et al.
Published: (2025-05-01)

Synthesis and Characterization of some Pyrazoline derivatives from Chalcones containing azo and ether groups
by: Ahmed A. ALKazmi, et al.
Published: (2023-02-01)

A Study of Antioxidant Properties and a Pharmacokinetic Investigation of Chalcones and Pyrazolines
by: André Luis Kerek, et al.
Published: (2025-05-01)

Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies
by: Raiane Dandara Pereira Pimentel, et al.
Published: (2025-07-01)

Hidden targets in dermatology: In vitro and In silico inhibitory effects of common 23 dermatologic drugs on human carbonic anhydrase isoenzymes I and II
by: İlkay Can, et al.
Published: (2025-12-01)

The use of angiotensin-converting enzyme inhibitors in general medicine
by: M.L.I. Mashitisho
Published: (2012-08-01)

Synthesis and biological evaluation of N-substituted indole chalcone derivatives as potent antitubercular agents
by: Shivam Joshi, et al.
Published: (2025-08-01)

In vitro and in silico neuroprotective evaluation of new biotransformation metabolites of (-)-α-bisabolol
by: Reham Mansour, et al.
Published: (2025-07-01)

Bilateral Choroidal Detachment Following Pseudophakic Cystoid Macular Edema Treatment with Oral Acetazolamide
by: Agnieszka Kudasiewicz-Kardaszewska, et al.
Published: (2025-05-01)

Development and validation of the method of quantification of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and its metabolites in laboratory animal plasma
by: I. I. Yaichkov, et al.
Published: (2024-09-01)

Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II
by: N. I. Kurysheva
Published: (2020-12-01)

Angiotensin Converting Enzyme Inhibitors: Interaction Issues in Patients with Glaucoma and Arterial Hypertension. Review
by: S. I. Makogon, et al.
Published: (2023-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Computational screening identifies selective aldose reductase inhibitors with strong efficacy and limited off target interactions
by: Jicli Jose Rojas, et al.
Published: (2025-08-01)

STUDI IN SILICO POTENSI SENYAWA ALLIIN BAWANG PUTIH (Allium sativum) SEBAGAI INHIBITOR DPP-4 PADA DIABETES MELLITUS
by: Martina Kurnia Rohmah
Published: (2018-03-01)

Prenylated chalcone analog-mediated Inhibition of Toxoplasma gondii growth in human trophoblast cell line and villous explants
by: Marina Paschoalino, et al.
Published: (2025-07-01)

Chemical Weapons in the Iran-Iraq War (1980–1988). 6. Accumulated Experience in the Treatment of Lesions with Poisonous Nerve Agents
by: M. V. Supotnitskiy
Published: (2023-06-01)

NEW ANTIPLATELET DRUGS. PART 2
by: A. B. Sumarokov
Published: (2016-01-01)

Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis
by: Xu Zhao, et al.
Published: (2025-06-01)

Design, synthesis and biological evaluation of aryl chalcone derivatives of pyridine-benzoxazole-pyimidine-oxazole as anticancer agents
by: Abdulrhman Alsayari, et al.
Published: (2025-07-01)

Fatal angioedema induced by angiotensin conversion enzyme (ACE) inhibitors
by: Marianne Tiemensma, et al.
Published: (2010-06-01)

Synthesis, in vitro activity, and computational evaluation of novel Thiadiazole derivatives as potent urease inhibitors
by: Naseer Ahmed, et al.
Published: (2025-07-01)

Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors
by: Hasset Tibebe, et al.
Published: (2025-03-01)

Development of mercapto-phenyl-1,2,4-triazole bearing thio-quinoline as a novel class of tyrosinase inhibitors: an in vitro and in silico study
by: Nazanin Motamedi Shakib, et al.
Published: (2025-07-01)

A comparative evaluation of the efficacy and safety of Latanoprost-Optic and Xalatan used as monotherapy and combined with Dorzolamide-Optic for primary open-angle glaucoma under clinical practice conditions
by: D. P. Novikov, et al.
Published: (2023-03-01)

Current Status and Future Perspectives of Immunotherapies in Bladder Cancer
by: Gökhan Çolak, et al.
Published: (2025-08-01)

Isolation of Allosteric Tryptase Inhibitor from Methanol Extract of Rhubarb and Enhancement of Its Tryptase Inhibitory Activity by Compounds That Were Screened by In Silico Screening
by: Hidetoshi Fujii, et al.
Published: (2025-03-01)

Novel and Potential Photoprotective and Tyrosinase Inhibitory Effects of <i>Tetrastigma erubescens</i> Extracts: Evidence from In Vitro Assays and Computational Approach
by: Thi Thu Le Vu, et al.
Published: (2025-06-01)

Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs
by: Hailong Yang, et al.
Published: (2025-05-01)

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib
by: Rima Hajjo, et al.
Published: (2025-06-01)

Identification of chalcone isomerase gene family in Astragalus mongholicus revealed genes regulating isoflavone synthesis
by: Zhen Wang, et al.
Published: (2025-08-01)

Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight
by: Francesca Falcinelli, et al.
Published: (2025-04-01)

Discovery of Dietary Plant Flavonols as Novel Potent Inhibitors Targeting DYRK1A Kinase
by: Jin Jin, et al.
Published: (2025-06-01)

Lesson from a metastatic male breast cancer case: CDK4/6 plus aromatase inhibitors could not exceed tamoxifen
by: Tala Najdi, et al.
Published: (2025-05-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)